"State-of-the-art care in a comforting environment. From the moment patients and visitors walk into M Health Fairview St. John's Hospital (formerly known as HealthEast St. John's Hospital), they experience our warm, inviting atmosphere and caring, personal staff. State-of-the-art technology, combined with the expertise of our specialists, nurses and staff, contribute to our innovative healing environment and personal, compassionate health care delivery. Our 184-bed facility offers a wide variety of diagnostic and therapeutic services. To meet the needs of our growing community, St. John's Hospital provides many innovative technologies and services."

During the past decade, Saint John's Hospital - Healtheast conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 141 clinical trials were completed, i.e. on average, 76.6% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 78 clinical trials were completed. i.e. 97.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint John's Hospital - Healtheast" #1 sponsor was "National Cancer Institute (NCI)" with 158 trials, followed by "Alliance for Clinical Trials in Oncology" with 47 trials sponsored, "SWOG Cancer Research Network" with 42 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint John's Hospital - Healtheast" #1 collaborator was "National Cancer Institute (NCI)" with 158 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator and "Cancer and Leukemia Group B" with 8 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Saint John's Hospital - Healtheast" are "Recurrent Ovarian Carcinoma" (14 trials), "Breast Cancer" (12 trials), "Recurrent Breast Carcinoma" (11 trials), "Invasive Breast Carcinoma" (10 trials) and "Ovarian Seromucinous Carcinoma" (10 trials). Many other conditions were trialed in "Saint John's Hospital - Healtheast" in a lesser frequency.

Most popular intervention types in "Saint John's Hospital - Healtheast" are "Drug" (250 trials), "Other" (196 trials), "Biological" (123 trials), "Procedure" (76 trials) and "Radiation" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (104 trials), "Quality-of-Life Assessment" (82 trials), "Questionnaire Administration" (51 trials), "Paclitaxel" (37 trials) and "Computed Tomography" (32 trials). Other intervention names were less common.

The vast majority of trials in "Saint John's Hospital - Healtheast" are 254 trials for "All" genders, 58 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Saint John's Hospital - Healtheast". undefined are not yet recruiting, 72 are recruiting, 134 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 87 completed trials in Saint John's Hospital - Healtheast, 7 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Saint John's Hospital - Healtheast, 9 "Phase 1" clinical trials were conducted, 155 "Phase 2" clinical trials and 146 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 15 trials that are defined as “Not Applicable".